Paul Hartmann AG (FRA:PHH2)

Market Cap	767.18M -6.1%
Revenue (ttm)	2.44B +1.9%
Net Income	81.51M +36.9%
EPS	22.94 +36.8%
Shares Out	3.55M
PE Ratio	9.42
Forward PE	n/a
Dividend	8.00 (3.70%)
Ex-Dividend Date	May 2, 2025

Volume	232
Average Volume	142
Open	215.00
Previous Close	215.00
Day's Range	214.00 - 216.00
52-Week Range	213.00 - 258.00
Beta	0.58
RSI	43.35
Earnings Date	Mar 20, 2026

About Paul Hartmann AG

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, con...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1818
• Employees: 10,082
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PHH2

Financial Performance

In 2024, Paul Hartmann AG's revenue was 2.43 billion, an increase of 2.46% compared to the previous year's 2.37 billion. Earnings were 108.45 million, an increase of 281.58%.